This peptide is restricted by human leukocyte antigen (HLA)-A2 and is designed to stimulate cytotoxic T lymphocytes (CTLs) to recognize and destroy HER2/neu-expressing cancer cells [264,283]. The gene discussed is ERBB2; the disease is cancer.